US Patent Issued to Arxx Therapeutics AS on May 20 for "Anti-S100A4 humanized antibodies, uses and methods" (Norwegian, British, American Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,304,949, issued on May 20, was assigned to Arxx Therapeutics AS (Norway).

"Anti-S100A4 humanized antibodies, uses and methods" was invented by Jonas Hallen (Oslo, Norway), Rizwan Iqbal Hussain (Oslo, Norway), Jorg Klingelhofer (Oslo, Norway), Tim Buss (Carlsbad, Calif.) and Darragh MacCann (Belfast, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "Herein are provided isolated, humanized, anti-S100A4 antibody molecules and methods of producing said antibodies. Also provided are nucleic acids, vectors, isolated host cells and pharmaceutical compositions containing the antibody, and methods of treatment comprising administering said antibody."...